Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer

Vaccine

Volumn 14, Issue 16, 1996, Pages 1485-1494

  Boursnell, M E G ^a   Rutherford, E ^a   Hickling, J K ^a   Rollinson, E A ^a   Munro, A J ^a   Rolley, N ^a   McLean, C S ^a   Borysiewicz, L K ^b   Vousden, K ^c   Inglis, S C ^a  

^a Cantab Pharmaceuticals Ltd   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical carcinoma; HPV; Vaccinia virus

Indexed keywords

CANCER VACCINE;

ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; HUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINIA VIRUS; VIRULENCE; VIRUS RECOMBINANT; WART VIRUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CANCER VACCINES; CARCINOMA; DNA-BINDING PROTEINS; FEMALE; GENES, VIRAL; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UTERINE CERVICAL NEOPLASMS; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL STRUCTURAL PROTEINS; VIRULENCE;

EID: 0030293807     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00117-X     Document Type: Article

References (40)

1. 1 zur Hausen, H. Viruses in human cancers. Science 1991, 254, 1167-1173
2. 2 van den Brule, A.J.C., Snijders, P.J.F., Meijer, C.J.L.M. and Walboomers, J.M.M. PCR based detection of genital HPV genotypes: An update and future perspectives. Papillomavirus Reports 1993, 4, 95-99
3. 3 Schwartz, E., Freese, U.K., Gissman, L. et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314, 111-114
4. 4 Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R. and Schiller, J.T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989, 8, 3905-3910
5. 5 Phelps, W.C., Yee, C.L., Münger, K. and Howley, P.M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 1988, 53, 539-547
6. 6 Dyson, N., Howley, P.M., Münger, K. and Harlow, E. The human papillomavirus type 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243, 934-937
7. 7 Münger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E. and Howley, P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumour suppressor gene product. EMBO J 1989, 8, 4099-4105
8. 8 Werness, B.A., Levine, A.J. and Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248, 76-79
9. 9 von Knebel Doeberitz, M., Ritmuller, C., Aengeneyndt, P., Jansendurr, D. and Spitovsky, D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells. Consequences for the phenotype and E6-p53 and E7-pRb interactions. J Virol 1994, 68, 2811-2821
10. 10 Townsend, A.R.M., Rothbard, J.B., Gotch, P.M., Bahadur, G., Wraith, D. and McMichael, A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986, 44, 959-968
11. 11 Rooney, C.M., Smith, C.A., Ng, C.Y.C. et al. Use of gene modified virus specific T lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet 1995, 345, 9-13
12. 12 Kawakami, Y, Eliyahu, S., Delgado, C.H. et al. Identification of a human melanoma antigen recognized by tumour infiltrating lymphocytes associated with in vivo tumour rejection. Proc Natl Acad Sci (USA) 1994, 91, 6458-6462
13. 13 Feltkamp, M.C.W., Smits, H.L., Vierboom, M.P.M. et al. Vaccination with cytotoxic T lymphocyte epitope containing peptide protects against a tumor induced by human papillomavirus type 16 cells. Eur J Immunol 1993, 23, 2242-2249
14. 14 Meneguzzi, G., Cerni, C., Kieny, M.P. and Lathe, R. Immunisation against human papillomavirus type 16 tumour cells with recombinant vaccinia viruses expressing E6 and E7. Virology 1991, 181, 62-69
15. 15 Chen, L.P., Thomas, E.K., Hu, S.L., Hellstrom, I. and Hellstrom, K.E. Human papillomavirus type 16 nucleoprotein E7 is a tumour rejection antigen. Proc Natl Acad Sci (USA) 1991, 88, 110-114
16. 16 Chen, L.P., Mizuno, M.T., Singhai, M.C. et al. Induction of cytotoxic T lymphocytes specific for a syngeneic tumour expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol 1992, 148, 2617-2621
17. 17 Barrany G. and Merrifield R. Solid phase peptide synthesis. In: The Peptides (Eds. Gross E. and Meienhofer J.), New York: Academic Press, 1979, 1-284
18. 18 Cole, S.T. and Danos, O. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. J Mol Biol 1987, 193, 599-608
19. 19 Brierley, I., Digard, P. and Inglis, S.C. Characterisation of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot. Cell 1989, 57, 537-547
20. 20 Barbosa, M.S., Edmonds, C., Fisher, C., Schiller, J.T., Lowy, D.R. and Vousden, K.H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J 1990, 9, 153-160
21. 21 Chesters, P.M., Edmonds, C., Vousden, K.H. and McCance, D.J. Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells. J Gen Virol 1990, 71, 449-453
22. 22 Morgenstern, J.P. and Land, H.D. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 1990, 18, 1068-1072
23. 23 Storey, A., Pim, D., Murray, A., Osborn, K., Banks, L. and Crawford, L. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988, 7, 1815-1820
24. 24 Shih, C. and Weinberg, R.A. Isolation of a transforming sequence from a human carcinoma cell line. Cell 1982, 29, 161-169
25. 25 Venkatesan, S., Baroudy, B.M. and Moss, B. Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell 1981, 125, 805-813
26. 26 Rosel, J.L., Earl, P.L., Weir, J.P. and Moss, B. Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the Hind III H genome fragment. J Virol 1986, 60, 436-449
27. 27 Falkner, F.G. and Moss, B. Transient dominant selection of recombinant vaccinia viruses. J Virol 1990, 64, 3108-3111
28. 28 Stacey, S.N., Eklund, C., Jordan, D. et al. Scanning the structure and antigenicity of HPV16 E6 and E7 oncoproteins using anti-peptide antibodies. Oncogene 1994, 9, 635-645
29. 29 Sadovnikova, E., Zhu, X., Collins, S.M. et al. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papillomavirus E7 protein. Int Immunol 1994, 6, 289-296
30. 30 Lane, J.M., Ruben, F.L., Neff, J.M. and Milar, J.D. Complications of smallpox vaccination 1968. National surveillance in the United States. New Engl J Med 1969, 281, 1201-1208
31. 31 Moss, B. and Flexner, C.H. Vaccinia virus expression vectors. Annu Rev Immunol 1987, 5, 305-324
32. 32 Bennink, J.R. and Yewdell, J.W. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr Top Microbiol Immunol 1990, 163, 153-184
33. 33 Estin, C.D., Stevenson, U.S., Plowman, G.D. et al. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy. Proc Natl Acad Sci (USA) 1988, 85, 1052-1056
34. 34 Hareuveni, M., Gautier, C., Kieny, M.-P., Wreschner, D., Chambon, P. and Lathe, R. Vaccination against tumour cells expressing breast cancer epithelial cell antigen. Proc Natl Acad Sci (USA) 1990, 87, 9498-9502
35. 35 Kantor, J., Irvine, K., Abrams, S., Kaufmann, H., DiPietro, J. and Schlom, J. Anti-tumour activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst 1992, 84, 1084-1091
36. 36 Rohrmann, G., Yuen, L. and Moss, B. Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence. Cell 1986, 46, 1029-1035
37. 37 Edmonds, C. and Vousden, K.H. A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 1989, 63, 2650-2656
38. 38 Smith, G.L., Chan, Y.S. and Howard, S.T. Nucleotide sequence of 42kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol 1991, 72, 1349-1376
39. 39 Andrew, M.E., Coupar, B.E., Boyle, D.B. and Blanden, R.V. Recognition by major histocompatibility class I restricted cytolytic T lymphocytes of vaccinia encoded viral and class I proteins. Eur J Immunol 1987, 17, 1515-1518
40. 40 Schendel, D.J., Gansbacher, B., Oberneder, R. et al. Tumour specific lysis of human renal cell carcinomas by tumour infiltrating lymphocytes. J Immunol 1993, 151, 4209-4220